Study of monoclonal antibody nirsevimab against Respiratory Syncytial Virus (RSV) in participants up to 24 months of age in India

Trial Identifier: VAS00017
Sponsor: Sanofi
Start Date: July 2025
Primary Completion Date: November 2026
Study Completion Date: November 2026
Condition: Respiratory Syncytial Virus Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
INDIA BENGALURU, INDIA, 560011
INDIA JAIPUR, INDIA, 302007
INDIA KOLKATA, INDIA, 700017
INDIA NAGPUR, INDIA, 441108
INDIA NEW DELHI, INDIA, 110060
INDIA PUNE, INDIA, 411007
INDIA Vizianagaram, INDIA, 535003